Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models

Dysregulation of the imprinted H19/IGF2 locus can lead to Silver-Russell syndrome (SRS) in humans. However, the mechanism of how abnormal H19/IGF2 expression contributes to various SRS phenotypes remains unclear, largely due to incomplete understanding of the developmental functions of these two gen...

Full description

Bibliographic Details
Main Authors: Suhee Chang, Diana Fulmer, Stella K Hur, Joanne L Thorvaldsen, Li Li, Yemin Lan, Eric A Rhon-Calderon, Nicolae Adrian Leu, Xiaowen Chen, Jonathan A Epstein, Marisa S Bartolomei
Format: Article
Language:English
Published: eLife Sciences Publications Ltd 2022-11-01
Series:eLife
Subjects:
Online Access:https://elifesciences.org/articles/78754
_version_ 1811215506463522816
author Suhee Chang
Diana Fulmer
Stella K Hur
Joanne L Thorvaldsen
Li Li
Yemin Lan
Eric A Rhon-Calderon
Nicolae Adrian Leu
Xiaowen Chen
Jonathan A Epstein
Marisa S Bartolomei
author_facet Suhee Chang
Diana Fulmer
Stella K Hur
Joanne L Thorvaldsen
Li Li
Yemin Lan
Eric A Rhon-Calderon
Nicolae Adrian Leu
Xiaowen Chen
Jonathan A Epstein
Marisa S Bartolomei
author_sort Suhee Chang
collection DOAJ
description Dysregulation of the imprinted H19/IGF2 locus can lead to Silver-Russell syndrome (SRS) in humans. However, the mechanism of how abnormal H19/IGF2 expression contributes to various SRS phenotypes remains unclear, largely due to incomplete understanding of the developmental functions of these two genes. We previously generated a mouse model with humanized H19/IGF2 imprinting control region (hIC1) on the paternal allele that exhibited H19/Igf2 dysregulation together with SRS-like growth restriction and perinatal lethality. Here, we dissect the role of H19 and Igf2 in cardiac and placental development utilizing multiple mouse models with varying levels of H19 and Igf2. We report severe cardiac defects such as ventricular septal defects and thinned myocardium, placental anomalies including thrombosis and vascular malformations, together with growth restriction in mouse embryos that correlated with the extent of H19/Igf2 dysregulation. Transcriptomic analysis using cardiac endothelial cells of these mouse models shows that H19/Igf2 dysregulation disrupts pathways related to extracellular matrix and proliferation of endothelial cells. Our work links the heart and placenta through regulation by H19 and Igf2, demonstrating that accurate dosage of both H19 and Igf2 is critical for normal embryonic development, especially related to the cardiac-placental axis.
first_indexed 2024-04-12T06:23:43Z
format Article
id doaj.art-6e1ce1ff28534687a37e77cf4367e911
institution Directory Open Access Journal
issn 2050-084X
language English
last_indexed 2024-04-12T06:23:43Z
publishDate 2022-11-01
publisher eLife Sciences Publications Ltd
record_format Article
series eLife
spelling doaj.art-6e1ce1ff28534687a37e77cf4367e9112022-12-22T03:44:13ZengeLife Sciences Publications LtdeLife2050-084X2022-11-011110.7554/eLife.78754Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse modelsSuhee Chang0https://orcid.org/0000-0002-0514-3516Diana Fulmer1https://orcid.org/0000-0001-7675-9951Stella K Hur2Joanne L Thorvaldsen3Li Li4Yemin Lan5Eric A Rhon-Calderon6Nicolae Adrian Leu7Xiaowen Chen8Jonathan A Epstein9https://orcid.org/0000-0001-8637-4465Marisa S Bartolomei10https://orcid.org/0000-0001-9410-5222Department of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Biomedical Sciences, School of Veterinary Medicine, Institute for Regenerative Medicine, University of Pennsylvania, Philadelphia, United StatesPenn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United States; Penn Cardiovascular Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDepartment of Cell and Developmental Biology, Epigenetics Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, United StatesDysregulation of the imprinted H19/IGF2 locus can lead to Silver-Russell syndrome (SRS) in humans. However, the mechanism of how abnormal H19/IGF2 expression contributes to various SRS phenotypes remains unclear, largely due to incomplete understanding of the developmental functions of these two genes. We previously generated a mouse model with humanized H19/IGF2 imprinting control region (hIC1) on the paternal allele that exhibited H19/Igf2 dysregulation together with SRS-like growth restriction and perinatal lethality. Here, we dissect the role of H19 and Igf2 in cardiac and placental development utilizing multiple mouse models with varying levels of H19 and Igf2. We report severe cardiac defects such as ventricular septal defects and thinned myocardium, placental anomalies including thrombosis and vascular malformations, together with growth restriction in mouse embryos that correlated with the extent of H19/Igf2 dysregulation. Transcriptomic analysis using cardiac endothelial cells of these mouse models shows that H19/Igf2 dysregulation disrupts pathways related to extracellular matrix and proliferation of endothelial cells. Our work links the heart and placenta through regulation by H19 and Igf2, demonstrating that accurate dosage of both H19 and Igf2 is critical for normal embryonic development, especially related to the cardiac-placental axis.https://elifesciences.org/articles/78754H19Igf2SRScardiac-placental axiscardiac developmentendothelial cells
spellingShingle Suhee Chang
Diana Fulmer
Stella K Hur
Joanne L Thorvaldsen
Li Li
Yemin Lan
Eric A Rhon-Calderon
Nicolae Adrian Leu
Xiaowen Chen
Jonathan A Epstein
Marisa S Bartolomei
Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models
eLife
H19
Igf2
SRS
cardiac-placental axis
cardiac development
endothelial cells
title Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models
title_full Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models
title_fullStr Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models
title_full_unstemmed Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models
title_short Dysregulated H19/Igf2 expression disrupts cardiac-placental axis during development of Silver-Russell syndrome-like mouse models
title_sort dysregulated h19 igf2 expression disrupts cardiac placental axis during development of silver russell syndrome like mouse models
topic H19
Igf2
SRS
cardiac-placental axis
cardiac development
endothelial cells
url https://elifesciences.org/articles/78754
work_keys_str_mv AT suheechang dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT dianafulmer dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT stellakhur dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT joannelthorvaldsen dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT lili dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT yeminlan dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT ericarhoncalderon dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT nicolaeadrianleu dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT xiaowenchen dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT jonathanaepstein dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels
AT marisasbartolomei dysregulatedh19igf2expressiondisruptscardiacplacentalaxisduringdevelopmentofsilverrussellsyndromelikemousemodels